Conversely, lower expression of KIF4A or specific mutations may suggest that patients could benefit from certain treatments; for instance, cervical cancer patients with reduced KIF4A expression demonstrated better responses to immunotherapy [111]. The gene discussed is KIF4A; the disease is cervical cancer.